C
Coral Laboratories Ltd Share Price
Pharmaceuticals
₹ (%)
- NSE
- BSE
What is Coral Laboratories Ltd revenue and profit growth?
- BSE Code 524506
- NSE Symbol
- ISIN Demat INE683E01017
- Book Value (₹) 596.89
- Face Value (₹) 10.00
- Market Cap (₹ Cr.) 152.42
- P/E (TTM) 10.67
- EPS (TTM) 40.01
- Div Yield (%) 0.00
Is Coral Laboratories Ltd financially strong enough to invest in?
Today’s Low
Today’s High
52W Low
52W High
Open
Prev. Close
Volume
What corporate actions has Coral Laboratories Ltd announced recently?
No Data Found
What is the history and background of Coral Laboratories Ltd?
Coral Laboratories Limited has been promoted by Navin B Doshi of the DWD group. The Company is spearheaded by Kishor R Mehta as Executive Director. CLL produces various pharmaceutical formulations.
To Manufacture pharmaceutical formulations like tablets,capsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully
CLL plans to expand its activities in the present premises by foraying into the sophisticated FFS (form fill and seal) technology for injections. The machinery for the said technology will be imported. The Coral group is also diversifying into housing construction and financial services for which a new company, Coral India Finance and Housing, will be incorporated.
During the year 1999-2000, the company has received ISO-9002 Certification.
| Founded | : 1981 |
| Address | : SF-206 Silver Oak Complex, BPC Road, Vadodara, Gujarat, 390020, |
Open A Free Demat Account Today
Get StartedDocuments To Be Kept Handy
- PAN Card
- Cancelled Cheque
- Latest 6 month Bank Statement (Only for Derivatives Trading)